{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:39:34Z","timestamp":1791272374577,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.cancergen.2012.03.002","type":"journal-article","created":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T08:41:22Z","timestamp":1338972082000},"page":"220-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Multiple CDK\/CYCLIND genes are amplified in medulloblastoma and supratentorial primitive neuroectodermal brain tumor"],"prefix":"10.1016","volume":"205","author":[{"given":"Meihua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zielenska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Northcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Shing","family":"Ra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bouffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisa","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Rutka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Eberhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia E.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy A.","family":"Squire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cancergen.2012.03.002_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<331::AID-CNCR18>3.0.CO;2-#","article-title":"Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors","volume":"86","author":"Russo","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2012.03.002_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2559.2005.02304.x","article-title":"Genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system","volume":"47","author":"Inda","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.cancergen.2012.03.002_bib3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00005072-200606000-00003","article-title":"High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors","volume":"65","author":"McCabe","year":"2006","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01052657","article-title":"Prognostic implications of chromosome 17p deletions in human medulloblastomas","volume":"24","author":"Batra","year":"1995","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jnen\/63.5.441","article-title":"Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia","volume":"63","author":"Eberhart","year":"2004","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib6","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1200\/JCO.2004.06.032","article-title":"Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma","volume":"22","author":"Gajjar","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1054\/bjoc.2001.1987","article-title":"Clinical and molecular stratification of disease risk in medulloblastoma","volume":"85","author":"Gilbertson","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cancergen.2012.03.002_bib8","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.1158\/0008-5472.CAN-04-1446","article-title":"Notch1 and notch2 have opposite effects on embryonal brain tumor growth","volume":"64","author":"Fan","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.03.002_bib9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/00006123-200010000-00020","article-title":"Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a review","volume":"47","author":"Taylor","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.cancergen.2012.03.002_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.neuro.24.1.385","article-title":"The developmental biology of brain tumors","volume":"24","author":"Wechsler-Reya","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.cancergen.2012.03.002_bib11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0959-8049(01)00315-X","article-title":"Paediatric embryonic brain tumors. biological and clinical relevance of molecular genetic abnormalities","volume":"38","author":"Gilbertson","year":"2002","journal-title":"Eur J\u00a0Cancer"},{"key":"10.1016\/j.cancergen.2012.03.002_bib12","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2012.03.002_bib13","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1038\/sj.onc.1202998","article-title":"The INK4 family of cell cycle inhibitors in cancer","volume":"18","author":"Roussel","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2012.03.002_bib14","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1073\/pnas.0336397100","article-title":"Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model","volume":"100","author":"Kannan","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2012.03.002_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-4608(97)00291-4","article-title":"Genomic amplification of CCND2 is rare in non-Hodgkin lymphomas","volume":"102","author":"Andreasson","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2012.03.002_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/mp.51.1.1","article-title":"Cyclin D1 and human neoplasia","volume":"51","author":"Donnellan","year":"1998","journal-title":"Mol Pathol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib17","first-page":"2624","article-title":"Disruption of the cyclin D\/cyclin-dependent kinase\/INK4\/retinoblastoma protein regulatory pathway in human neuroblastoma","volume":"58","author":"Easton","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.03.002_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molmed.2004.02.005","article-title":"The activities of cyclin D1 that drive tumorigenesis","volume":"10","author":"Ewen","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.cancergen.2012.03.002_bib19","first-page":"1065","article-title":"Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene","volume":"13","author":"Ichimura","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2012.03.002_bib20","first-page":"1250","article-title":"Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA","volume":"57","author":"Costello","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.03.002_bib21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1750-3639.1999.tb00532.x","article-title":"Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas","volume":"9","author":"B\u00fcschges","year":"1999","journal-title":"Brain Pathol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4161\/cc.5.4.2475","article-title":"The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma","volume":"5","author":"Uziel","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cancergen.2012.03.002_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ng1307","article-title":"A\u00a0tiling resolution DNA microarray with complete coverage of the human genome","volume":"36","author":"Ishkanian","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2012.03.002_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1476-5586(03)80017-9","article-title":"Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization","volume":"5","author":"Beheshti","year":"2003","journal-title":"Neoplasia"},{"key":"10.1016\/j.cancergen.2012.03.002_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/003130299104693","article-title":"Oncogene amplification in medulloblastoma: analysis of a case by comparative genomic hybridization and fluorescence in situ hybridization","volume":"31","author":"Jay","year":"1999","journal-title":"Pathology"},{"key":"10.1016\/j.cancergen.2012.03.002_bib26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/gcc.20157","article-title":"An integrated mBAND and submegabase resolution tiling set (SMRT) CGH array analysis of focal amplification, microdeletions, and ladder structures consistent with breakage-fusion-bridge cycle events in osteosarcoma","volume":"42","author":"Lim","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.03.002_bib27","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1158\/1078-0432.CCR-03-0721","article-title":"Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients","volume":"10","author":"Lamont","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2012.03.002_bib28","doi-asserted-by":"crossref","first-page":"7613","DOI":"10.1158\/1078-0432.CCR-04-0499","article-title":"A\u00a0clinicobiological model predicting survival in medulloblastoma","volume":"10","author":"Ray","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2012.03.002_bib29","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.1158\/0008-5472.CAN-05-0500","article-title":"Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells","volume":"65","author":"Huang","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.03.002_bib30","series-title":"User Bulletin #2: Relative quantitation of gene expression","year":"1997"},{"key":"10.1016\/j.cancergen.2012.03.002_bib31","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.cancergen.2012.03.002_bib32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.tibs.2005.09.005","article-title":"Mammalian cyclin-dependent kinases","volume":"30","author":"Malumbres","year":"2005","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.cancergen.2012.03.002_bib33","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.1074\/jbc.271.14.8313","article-title":"Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites","volume":"271","author":"Knudsen","year":"1996","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cancergen.2012.03.002_bib34","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/MCB.18.2.753","article-title":"Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes","volume":"18","author":"Lundberg","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4161\/cc.5.1.2265","article-title":"Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3: differential involvement in the distinct mitogenic modes of thyroid epithelial cells","volume":"5","author":"Paternot","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cancergen.2012.03.002_bib36","doi-asserted-by":"crossref","first-page":"12738","DOI":"10.1074\/jbc.272.19.12738","article-title":"Differential phosphorylation of the retinoblastoma protein by G1\/S cyclin-dependent kinases","volume":"272","author":"Zarkowska","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cancergen.2012.03.002_bib37","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1200\/JCO.2005.02.8589","article-title":"Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma","volume":"23","author":"Mendrzyk","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib38","doi-asserted-by":"crossref","first-page":"e6159","DOI":"10.1371\/journal.pone.0006159","article-title":"Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma","volume":"4","author":"Lu","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cancergen.2012.03.002_bib39","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1128\/MCB.21.14.4684-4699.2001","article-title":"Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis","volume":"21","author":"Ishida","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1101\/gad.949802","article-title":"E2F integrates cell cycle progression with DNA repair, replication, and G(2)\/M checkpoints","volume":"16","author":"Ren","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.cancergen.2012.03.002_bib41","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1038\/sj.emboj.7600459","article-title":"E2Fs link the control of G1\/S and G2\/M transcription","volume":"23","author":"Zhu","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.cancergen.2012.03.002_bib42","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1158\/0008-5472.CAN-04-4195","article-title":"Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity","volume":"65","author":"Sotillo","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.03.002_bib43","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1158\/1535-7163.1427.3.11","article-title":"Specific inhibition of cyclin-dependent kinase 4\/6 by PD 0332991 and associated antitumor activity in human tumor xenografts","volume":"3","author":"Fry","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.cancergen.2012.03.002_bib44","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1101\/gad.1368605","article-title":"The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation","volume":"19","author":"Uziel","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.cancergen.2012.03.002_bib45","first-page":"5428","article-title":"A\u00a0molecular fingerprint for medulloblastoma","volume":"63","author":"Lee","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.03.002_bib46","first-page":"113","article-title":"Transcriptional up-regulation of Gadd45a in Patched-associated medulloblastoma","volume":"25","author":"Kappler","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib47","first-page":"534","article-title":"Transcriptional profiling of medulloblastoma in children","volume":"99","author":"Park","year":"2003","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.cancergen.2012.03.002_bib48","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1038\/sj.onc.1207475","article-title":"Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization","volume":"23","author":"Yokota","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2012.03.002_bib49","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1101\/gad.14.8.994","article-title":"Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum","volume":"14","author":"Marino","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.cancergen.2012.03.002_bib50","first-page":"5420","article-title":"Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c\/p53-null mice","volume":"63","author":"Zindy","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.03.002_bib51","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1128\/MCB.20.1.372-378.2000","article-title":"INK4d-deficient mice are fertile despite testicular atrophy","volume":"20","author":"Zindy","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib52","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1242\/dev.02556","article-title":"Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation","volume":"133","author":"Pogoriler","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.cancergen.2012.03.002_bib53","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1158\/0008-5472.CAN-06-2973","article-title":"Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors","volume":"67","author":"Olson","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.03.002_bib54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.molbrainres.2003.11.016","article-title":"The TP53-ARF tumor suppressor pathway is frequently disrupted in large\/cell anaplastic medulloblastoma","volume":"121","author":"Frank","year":"2004","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.cancergen.2012.03.002_bib55","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00439-007-0386-3","article-title":"High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor","volume":"122","author":"Jackson","year":"2007","journal-title":"Hum Genet"},{"key":"10.1016\/j.cancergen.2012.03.002_bib56","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng.336","article-title":"Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma","volume":"41","author":"Northcott","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2012.03.002_bib57","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ccr.2009.10.025","article-title":"Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors","volume":"16","author":"Li","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergen.2012.03.002_bib58","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1200\/JCO.2008.17.9432","article-title":"Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci","volume":"27","author":"Pfister","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/02688690042870","article-title":"Expression of p19INK4d, CDK4, CDK6 in glioblastoma multiforme","volume":"14","author":"Lam","year":"2000","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.cancergen.2012.03.002_bib60","first-page":"759","article-title":"Insights from animal models on the origins and progression of retinoblastoma","volume":"6","author":"Pacal","year":"2006","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.cancergen.2012.03.002_bib61","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1200\/JCO.2010.28.5148","article-title":"Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome","volume":"29","author":"Cho","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib62","doi-asserted-by":"crossref","first-page":"e3088","DOI":"10.1371\/journal.pone.0003088","article-title":"Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features","volume":"3","author":"Kool","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.cancergen.2012.03.002_bib63","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1200\/JCO.2009.27.4324","article-title":"Medulloblastoma comprises four distinct molecular variants","volume":"29","author":"Northcott","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib64","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","article-title":"Molecular subgroups of medulloblastoma: the current consensus","volume":"123","author":"Taylor","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib65","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1200\/JCO.2005.04.4974","article-title":"Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations","volume":"24","author":"Thompson","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.03.002_bib66","doi-asserted-by":"crossref","first-page":"9413","DOI":"10.1158\/0008-5472.CAN-09-2158","article-title":"Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis","volume":"69","author":"He","year":"2009","journal-title":"Cancer Res"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212000683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212000683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:38:14Z","timestamp":1761896294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776212000683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S2210776212000683"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.03.002","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple CDK\/CYCLIND genes are amplified in medulloblastoma and supratentorial primitive neuroectodermal brain tumor","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}